Aurobindo Pharma has informed that a Meeting of the Board of Directors of the Company will be held on May 28, 2015, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2015. Further at the said Board meeting the Board will also consider payment of Dividend, if any, for the year 2014-15.The ‘Trading Window’ of the Company shall remain closed from May 18, 2015 to June 01, 2015), in view of consideration of Audited Financial Results of the Company for the year ended March 31, 2015 at the Board Meeting to be held on May 28, 2015. During this period any purchase , sale or other dealings in the shares of the Company is prohibited to all the Directors / Officers/ Employees of the Company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.35 |
| Dr. Reddys Lab | 1236.85 |
| Cipla | 1232.80 |
| Zydus Lifesciences | 942.40 |
| Lupin | 2332.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: